What Does the PhV Service Include?
PhV, or pharmacovigilance, refers to the monitoring of the safety of medicinal products. It encompasses activities aimed at overseeing drug safety throughout the product lifecycle, both during clinical trials and after a product has been authorized for marketing. The primary objective of pharmacovigilance is the early detection, assessment, and reporting of information that may have an impact on patient safety.
In practice, pharmacovigilance services primarily involve the management of adverse event reports—that is, situations in which a patient experiences an undesirable event that may be associated with the use of a medicinal product. These reports may originate from physicians, patients, research sites, sponsors, medical representatives, or other parties involved in patient care or the conduct of a clinical study.
Pharmacovigilance activities include receiving and processing reports, verifying the information provided, assessing data completeness, classifying adverse events, preparing the necessary documentation, and reporting cases to the appropriate regulatory authorities or reporting systems. In clinical trials, particular attention is given to adverse events (AEs), serious adverse events (SAEs), and suspected unexpected serious adverse reactions (SUSARs), all of which require proper evaluation and timely reporting.
PhV services may also include the development of safety procedures, support in preparing risk management plans, maintenance of safety databases, literature monitoring, preparation of periodic safety reports, and ongoing communication with key stakeholders such as sponsors, CROs, research sites, and regulatory authorities.
Pharmacovigilance plays a critical role in ensuring the quality and safety of medical treatments. Continuous safety monitoring enables the rapid identification of potential risks, supports the implementation of risk minimization measures, and helps ensure compliance with applicable legal and regulatory requirements. This is particularly important in clinical research, where participant safety is one of the highest priorities.
In summary, pharmacovigilance services provide comprehensive support for the safety management of medicinal products—from receiving and assessing safety reports, through documentation and regulatory reporting, to ensuring compliance with pharmacovigilance obligations. It is a discipline that combines medical expertise, regulatory knowledge, and meticulous procedural accuracy.
